Apollo Hospitals Enterprise Limited

NSE:APOLLOHOSP.NS

6858.85 (INR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 50,85649,43948,50648,46944,17843,02242,635.842,510.737,95634,199.936,389.337,170.737,602.127,759.427,598.427,607.221,71528,471.329,117.428,407.425,718.924,759.8724,950.424,124.222,104.7
Cost of Revenue 34,58533,80325,33124,58522,68222,341.922,160.621,718.619,521.218,156.918,235.318,723.320,619.514,750.214,865.415,05112,175.314,711.114,171.513,728.712,377.611,986.9412,100.711,738.210,782.9
Gross Profit 16,27115,63623,17523,88421,49620,680.120,475.220,792.118,434.816,04318,15418,447.416,982.613,009.212,73312,556.29,539.713,760.214,945.914,678.713,341.312,772.9312,849.712,38611,321.8
Gross Profit Ratio 0.320.3160.4780.4930.4870.4810.480.4890.4860.4690.4990.4960.4520.4690.4610.4550.4390.4830.5130.5170.5190.5160.5150.5130.512
Reseach & Development Expenses 0234000211000110000000000000000
General & Administrative Expenses 04,5480003,494.10001,0210003,928.90001,0770003,637000
Selling & Marketing Expenses 06,5800006,3970003,6480001,9980002,2710001,839000
SG&A 11,29411,12810,90911,16810,4889,891.19,7749,7309,053.24,6697,887.87,729.37,3495,926.90003,3480005,476000
Other Expenses 0281278222282163.5353.6225.7160.6-313.2171.556.3246.4-60.455113.277.2-120.296.63598.6-107.43124.925.546.4
Operating Expenses 11,29411,12818,70819,24318,07517,389.216,955.616,688.515,005.213,03513,773.713,745.113,189.510,031.610,080.311,052.410,786.711,563.112,218.812,08911,144.210,535.9511,042.810,6329,948.3
Operating Income 4,9774,5084,7594,8843,4213,490.13,657.84,197.73,429.63,008.14,380.34,702.33,793.12,977.62,652.71,503.8-1,2472,197.12,727.12,589.72,197.12,236.981,806.91,7541,373.5
Operating Income Ratio 0.0980.0910.0980.1010.0770.0810.0860.0990.090.0880.120.1270.1010.1070.0960.054-0.0570.0770.0940.0910.0850.090.0720.0730.062
Total Other Income Expenses Net -677-912-834-851-721-472.9-860.6-832.9-886.8-651-705.6-872.42,199.2-609.7-799.3-847.8-1,423-2,295.9-1,274.1-1,253.2-1,253.1-1,117.77-776.8-794.8-746.7
Income Before Tax 4,3003,5963,6333,7902,7002,5362,658.23,270.72,542.82,2843,674.73,829.95,992.32,367.91,853.4656-2,6702,866.51,4531,336.59441,119.211,030.1959.2626.8
Income Before Tax Ratio 0.0850.0730.0750.0780.0610.0590.0620.0770.0670.0670.1010.1030.1590.0850.0670.024-0.1230.1010.050.0470.0370.0450.0410.040.028
Income Tax Expense 1,1451,0981,0891,3029661,079.61,035.11,142.3-6951,386.51,242.21,155.8985.5676.7511.866-407.6740.5553.4505.5452.5390.93531.4418.1393.4
Net Income 3,0522,5382,4532,3291,6661,445.51,5352,039.93,171.1901.32,283.72,478.14,892.81,678.91,304.3602.7-2,081.92,192.2921.4862.4572816.26570.5634.1339.4
Net Income Ratio 0.060.0510.0510.0480.0380.0340.0360.0480.0840.0260.0630.0670.130.060.0470.022-0.0960.0770.0320.030.0220.0330.0230.0260.015
EPS 21.2317.6517.0616.211.5910.0510.6714.1922.056.2715.8817.2434.0312.079.384.33-14.9715.756.626.24.115.864.14.562.44
EPS Diluted 21.2317.6517.0616.211.5910.0510.6714.1922.046.2715.8817.2434.0312.079.384.33-14.9715.756.626.24.115.864.14.562.44
EBITDA 7,1236,6866,4156,5165,3725,0455,407.15,879.45,0684,939.66,041.76,206.28,386.24,574.83,957.93,465.94323,179.84,396.84,2253,641.82,913.212,9162,740.42,339.6
EBITDA Ratio 0.140.130.1330.1340.1230.1180.1220.1350.130.1230.1680.1680.1440.1440.1490.1090.0090.1120.1510.1490.1420.1210.1150.1140.106